Pharvaris NV

NASDAQ:PHVS  
19.73
+1.90 (+10.66%)
4:00:03 PM EDT: $19.73 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Pharvaris NV Stock, NASDAQ:PHVS

Emmy Noetherweg 2, J.H. Oortweg 21, Leiden, Zuid-Holland 2333 BK
Netherlands
Phone: +31.71.203.64.10
Number of Employees: 82
http://www.pharvaris.com

Description

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.